Antimicrobial dosing recommendations during continuous renal replacement therapy: different databases, different doses

被引:1
|
作者
Pehlivanli, Aysel [1 ,2 ,5 ]
Yalcin, Tugba Yanik [3 ]
Yesiler, Fatma Irem [4 ]
Sahinturk, Helin [4 ]
Azap, Ozlem Kurt [3 ]
Zeyneloglu, Pinar [4 ]
Basgut, Bilgen [1 ,2 ]
机构
[1] Baskent Univ, Fac Pharm, Pharmacol Dept, Ankara, Turkiye
[2] Baskent Univ, Ankara Hosp, Clin Pharm & Drug Informat Ctr, Ankara, Turkiye
[3] Baskent Univ, Fac Med, Infect Dis & Clin Microbiol Dept, Ankara, Turkiye
[4] Baskent Univ, Fac Med, Anesthesiol & Crit Care Unit Dept, Ankara, Turkiye
[5] Baskent Univ, Fac Pharm, Pharmacol Dept, TR-06000 Ankara, Turkiye
关键词
CRRT; sepsis; antimicrobial dosing; antimicrobial stewardship; databases; gold standard; pharmacokinetics; CRITICALLY-ILL PATIENTS; CONTINUOUS VENOVENOUS HEMOFILTRATION; ACUTE KIDNEY INJURY; POPULATION PHARMACOKINETICS; SEPTIC PATIENTS; GUIDELINE; DOSAGE; PHARMACODYNAMICS; STEWARDSHIP; INFORMATION;
D O I
10.1080/1120009X.2024.2321015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Meticulous antimicrobial management is essential among critically ill patients with acute kidney injury, particularly if renal replacement therapy is needed. Many factors affect drug removal in patients undergoing continuous renal replacement therapy CRRT. In this study, we aimed to compare current databases that are frequently used to adjust CRRT dosages of antimicrobial drugs with the gold standard. The dosage recommendations from various databases for antimicrobial drugs eliminated by CRRT were investigated. The book 'Renal Pharmacotherapy: Dosage Adjustment of Medications Eliminated by the Kidneys' was chosen as the gold standard. There were variations in the databases. Micromedex, UpToDate, and Sanford had similar rates to the gold standard of 45%, 35%, and 30%, respectively. The Micromedex database shows the most similar results to the gold standard source. In addition, a consensus was reached as a result of the expert panel meetings established to discuss the different antimicrobial dose recommendations of the databases.
引用
收藏
页码:474 / 482
页数:9
相关论文
共 50 条
  • [21] Drug dosing considerations in continuous renal replacement therapy
    Jang, Soo Min
    Awdishu, Linda
    SEMINARS IN DIALYSIS, 2021, 34 (06) : 480 - 488
  • [22] A pharmacokinetic study to guide dosing of tenofovir disoproxil fumarate during different modalities of renal replacement therapy
    Dams, Karolien
    Burger, David M.
    Weyler, Jonas
    Francque, Sven
    Jorens, Philippe G.
    Vanwolleghem, Thomas
    CLINICAL BIOCHEMISTRY, 2020, 83 : 86 - 88
  • [23] Antibiotic dosing table for continuous renal replacement therapy
    Fish, JT
    CRITICAL CARE MEDICINE, 2003, 31 (12) : A130 - A130
  • [24] Principles of Antibacterial Dosing in Continuous Renal Replacement Therapy
    Choi, Gordon
    Gomersall, Charles D.
    Tian, Qi
    Joynt, Gavin M.
    Li, Alexander M. M. Y.
    Lipman, Jeffrey
    BLOOD PURIFICATION, 2010, 30 (03) : 195 - 212
  • [25] Management of drug dosing in continuous renal replacement therapy
    Kroh, UF
    Holl, TJ
    Steinhusser, W
    SEMINARS IN DIALYSIS, 1996, 9 (02) : 161 - 165
  • [26] Antifungal dosing in dialysis and continuous renal replacement therapy
    Fish D.N.
    Current Fungal Infection Reports, 2011, 5 (2) : 75 - 82
  • [27] Antibiotic dosing for renal function disorders and continuous renal replacement therapy
    Michael, Erik
    Kindgen-Milles, Detlef
    ANAESTHESIST, 2015, 64 (04): : 315 - 323
  • [28] Vitamin C dosing during continuous renal replacement therapy: The last word is not said!
    Honore, Patrick M.
    De Bels, David
    Kugener, Luc
    Redant, Sebastien
    Attou, Rachid
    Gallerani, Andrea
    Spapen, Herbert D.
    JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2019, 7 (03) : 121 - 122
  • [29] Drug dosing in continuous renal replacement therapy: general rules
    Schetz, Miet
    CURRENT OPINION IN CRITICAL CARE, 2007, 13 (06) : 645 - 651
  • [30] Cefiderocol Dosing for Patients Receiving Continuous Renal Replacement Therapy
    Wei, Xiaohui
    Naseer, Shabnam
    Weinstein, Edward A.
    Iarikov, Dmitri
    Nambiar, Sumathi
    Reynolds, Kellie S.
    Jang, Seong H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (05) : 1004 - 1007